Eli Casdin - Net Worth and Insider Trading

Eli Casdin Net Worth

The estimated net worth of Eli Casdin is at least $211 Million dollars as of 2024-12-26. Eli Casdin is the Director of IPSCO Tubulars Inc and owns about 5,662,760 shares of IPSCO Tubulars Inc (IPSC) stock worth over $175 Million. Eli Casdin is the Director of Absci Corp and owns about 7,718,593 shares of Absci Corp (ABSI) stock worth over $24 Million. Eli Casdin is also the Director of Tenaya Therapeutics Inc and owns about 6,078,860 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $10 Million. Besides these, Eli Casdin also holds Standard BioTools Inc (LAB) . Details can be seen in Eli Casdin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eli Casdin has not made any transactions after 2023-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eli Casdin

Eli Casdin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eli Casdin owns 14 companies in total, including CM Life Sciences Inc (CMLFU) , Exact Sciences Corp (EXAS) , and BioLife Solutions Inc (BLFS) among others .

Click here to see the complete history of Eli Casdin’s form 4 insider trades.

Insider Ownership Summary of Eli Casdin

Ticker	Comapny	Transaction Date	Type of Owner
CMLFU	CM Life Sciences Inc	2020-09-01	director & 10 percent owner & Chief Executive Officer
EXAS	Exact Sciences Corp	2017-10-26	director
BLFS	BioLife Solutions Inc	2018-08-10	10 percent owner
		2020-06-11	10 percent owner
		2019-07-17	10 percent owner
		2018-07-23	10 percent owner
		2023-05-19	director & 10 percent owner
		2021-07-29	10 percent owner
		2021-07-26	director & 10 percent owner
		2023-01-31	director & 10 percent owner
		2022-09-29	director
		2021-12-17	director & 10 percent owner
		2022-06-09	director
		2022-11-17	director

Eli Casdin Latest Holdings Summary

Eli Casdin currently owns a total of 4 stocks. Among these stocks, Eli Casdin owns 5,662,760 shares of IPSCO Tubulars Inc (IPSC) as of June 22, 2021, with a value of $175 Million and a weighting of 83.06%. Eli Casdin owns 7,718,593 shares of Absci Corp (ABSI) as of July 26, 2021, with a value of $24 Million and a weighting of 11.2%. Eli Casdin also owns 6,078,860 shares of Tenaya Therapeutics Inc (TNYA) as of November 17, 2022, with a value of $10 Million and a weighting of 4.65%. The other 1 stocks Standard BioTools Inc (LAB) have a combined weighting of 1.1% among all his current holdings.

Latest Holdings of Eli Casdin

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
IPSC	IPSCO Tubulars Inc	2021-06-22	5,662,760	30.88	174,866,029
ABSI	Absci Corp	2021-07-26	7,718,593	3.06	23,580,302
TNYA	Tenaya Therapeutics Inc	2022-11-17	6,078,860	1.61	9,786,965
LAB	Standard BioTools Inc	2023-05-19	1,246,766	1.85	2,306,517

Holding Weightings of Eli Casdin

Eli Casdin Form 4 Trading Tracker

According to the SEC Form 4 filings, Eli Casdin has made a total of 1 transactions in IPSCO Tubulars Inc (IPSC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IPSCO Tubulars Inc is the acquisition of 750,000 shares on June 22, 2021, which cost Eli Casdin around $15 Million.

According to the SEC Form 4 filings, Eli Casdin has made a total of 1 transactions in Absci Corp (ABSI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Absci Corp is the acquisition of 1,562,500 shares on July 26, 2021, which cost Eli Casdin around $25 Million.

According to the SEC Form 4 filings, Eli Casdin has made a total of 2 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,492,042 shares on November 17, 2022, which cost Eli Casdin around $6 Million.

More details on Eli Casdin's insider transactions can be found in the Insider Trading History of Eli Casdin table.

Insider Trading History of Eli Casdin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eli Casdin Trading Performance

GuruFocus tracks the stock performance after each of Eli Casdin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eli Casdin is 9.65%. GuruFocus also compares Eli Casdin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eli Casdin within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eli Casdin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eli Casdin

Average Return

Average return per transaction

Outperforming Transactions

1 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.15
Relative Return to S&P 500(%)	1.54

Eli Casdin Ownership Network

Ownership Network List of Eli Casdin

No Data

Ownership Network Relation of Eli Casdin

Eli Casdin Owned Company Details

What does CM Life Sciences Inc do?

Who are the key executives at CM Life Sciences Inc?

Eli Casdin is the director & 10 percent owner & Chief Executive Officer of CM Life Sciences Inc. Other key executives at CM Life Sciences Inc include and director & 10 percent owner Keith A. Meister .

CM Life Sciences Inc (CMLFU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CM Life Sciences Inc (CMLFU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CM Life Sciences Inc (CMLFU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CM Life Sciences Inc (CMLFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

CM Life Sciences Inc Insider Transactions

No Available Data

What does Exact Sciences Corp do?

Who are the key executives at Exact Sciences Corp?

Eli Casdin is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include director & Vice President Kevin T Conroy , Gen. Mgr. & Precision Oncology Brian Baranick , and General Counsel James Herriott .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 20,284 shares made by Sarah Condella , a net sale of 11,459 shares made by Brian Baranick , and a net sale of 40,200 shares made by Jeffrey Thomas Elliott .

In summary, during the past 3 months, insiders sold 929 shares of Exact Sciences Corp (EXAS) in total and bought 19,500 shares, with a net purchase of 18,571 shares. During the past 18 months, 162,623 shares of Exact Sciences Corp (EXAS) were sold and 19,500 shares were bought by its insiders, resulting in a net sale of 143,123 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Exact Sciences Corp Insider Transactions

No Available Data

What does BioLife Solutions Inc do?

Who are the key executives at BioLife Solutions Inc?

Eli Casdin is the 10 percent owner of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include Chief Tech. Officer & Sr. VP Aby J. Mathew , Vice President & Marketing Todd Berard , and Vice President of Operations Karen A. Foster .

BioLife Solutions Inc (BLFS) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 138,875 shares made by Aby J. Mathew , a net sale of 44,020 shares made by Todd Berard , and a net sale of 12,253 shares made by Karen A. Foster .

In summary, during the past 3 months, insiders sold 87,984 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 87,984 shares. During the past 18 months, 337,921 shares of BioLife Solutions Inc (BLFS) were sold and 985,630 shares were bought by its insiders, resulting in a net purchase of 647,709 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioLife Solutions Inc Insider Transactions

No Available Data

What does Generation Bio Co do?

Who are the key executives at Generation Bio Co?

Eli Casdin is the 10 percent owner of Generation Bio Co. Other key executives at Generation Bio Co include CHIEF OPERATING OFFICER Antoinette Paone , CHIEF LEGAL OFFICER Yalonda Howze , and CHIEF STRATEGY OFFICER Phillip Samayoa .

Generation Bio Co (GBIO) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 20,000 shares made by Dannielle Appelhans , a net sale of 9,835 shares made by Antoinette Paone , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,835 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 541,620 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Generation Bio Co Insider Transactions

No Available Data

What does Fulcrum Therapeutics Inc do?

Who are the key executives at Fulcrum Therapeutics Inc?

Eli Casdin is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .

Fulcrum Therapeutics Inc (FULC) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fulcrum Therapeutics Inc Insider Transactions

No Available Data

What does Constellation Pharmaceuticals Inc do?

Who are the key executives at Constellation Pharmaceuticals Inc?

Eli Casdin is the 10 percent owner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .

Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Constellation Pharmaceuticals Inc Insider Transactions

No Available Data

What does Standard BioTools Inc do?

Who are the key executives at Standard BioTools Inc?

Eli Casdin is the director & 10 percent owner of Standard BioTools Inc. Other key executives at Standard BioTools Inc include director & 10 percent owner Casdin Partners Master Fund, L.p. , SVP & Chief Financial Officer Jeffrey G. Black , and director & 10 percent owner Casdin Partners Gp, Llc .

Standard BioTools Inc (LAB) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Standard BioTools Inc (LAB). Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 9,598,445 shares made by Casdin Partners Master Fund, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Standard BioTools Inc (LAB) were sold and 9,598,445 shares were bought by its insiders, resulting in a net purchase of 9,598,445 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Standard BioTools Inc Insider Transactions

No Available Data

What does MaxCyte Inc do?

Who are the key executives at MaxCyte Inc?

Eli Casdin is the 10 percent owner of MaxCyte Inc. Other key executives at MaxCyte Inc include EVP & Global Sales Thomas M. Ross , EVP and General Counsel Maher Masoud , and director & President and CEO Douglas Doerfler .

MaxCyte Inc (MXCT) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in MaxCyte Inc (MXCT). Other recent insider transactions involving MaxCyte Inc (MXCT) include a net sale of 85,000 shares made by John Joseph Johnston , a net sale of 180,000 shares made by Douglas Doerfler , and a net sale of 143,067 shares made by Stanley C Erck .

In summary, during the past 3 months, insiders sold 101,378 shares of MaxCyte Inc (MXCT) in total and bought 0 shares, with a net sale of 101,378 shares. During the past 18 months, 508,066 shares of MaxCyte Inc (MXCT) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 408,066 shares.

MaxCyte Inc (MXCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

MaxCyte Inc Insider Transactions

No Available Data

What does Absci Corp do?

Who are the key executives at Absci Corp?

Eli Casdin is the director & 10 percent owner of Absci Corp. Other key executives at Absci Corp include 10 percent owner Phoenix Venture Partners Ii Lp , director & 10 percent owner Redmile Group, Llc , and General Counsel Sarah Korman .

Absci Corp (ABSI) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net sale of 3,100,000 shares made by Phoenix Venture Partners Ii Lp , a net purchase of 222,222 shares made by Redmile Group, Llc , and a net sale of 19,859 shares made by Zachariah Jonasson .

In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,119,859 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net sale of 2,897,637 shares.

Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Absci Corp Insider Transactions

No Available Data

What does GeneDx Holdings Corp do?

Who are the key executives at GeneDx Holdings Corp?

Eli Casdin is the director & 10 percent owner of GeneDx Holdings Corp. Other key executives at GeneDx Holdings Corp include director & Chief Executive Officer Katherine Stueland , Chief Financial Officer Kevin Feeley , and 10 percent owner Icahn School Of Medicine At Mount Sinai .

GeneDx Holdings Corp (WGS) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in GeneDx Holdings Corp (WGS). Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 48,600 shares made by Kevin Feeley , a net sale of 131,023 shares made by Katherine Stueland , and a net sale of 7,824 shares made by Kareem Saad .

In summary, during the past 3 months, insiders sold 1,149,074 shares of GeneDx Holdings Corp (WGS) in total and bought 0 shares, with a net sale of 1,149,074 shares. During the past 18 months, 3,042,909 shares of GeneDx Holdings Corp (WGS) were sold and 560,642 shares were bought by its insiders, resulting in a net sale of 2,482,267 shares.

GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

GeneDx Holdings Corp Insider Transactions

No Available Data

What does SomaLogic Inc do?

Who are the key executives at SomaLogic Inc?

Eli Casdin is the director of SomaLogic Inc. Other key executives at SomaLogic Inc include Chief People Officer Alison Marie Roelke , General Counsel Ruben Gutierrez , and Interim CEO Adam Taich .

SomaLogic Inc (SLGC) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in SomaLogic Inc (SLGC). Other recent insider transactions involving SomaLogic Inc (SLGC) include a net sale of 9,109 shares made by Alison Marie Roelke , a net sale of 22,996 shares made by Adam Taich , and a net sale of 9,976 shares made by Ruben Gutierrez .

In summary, during the past 3 months, insiders sold 0 shares of SomaLogic Inc (SLGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,081 shares of SomaLogic Inc (SLGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,081 shares.

SomaLogic Inc (SLGC)'s detailed insider trading history can be found in Insider Trading Tracker table.

SomaLogic Inc Insider Transactions

No Available Data

What does EQRx Inc do?

Who are the key executives at EQRx Inc?

Eli Casdin is the director & 10 percent owner of EQRx Inc. Other key executives at EQRx Inc include General Counsel and Secretary Dina Ciarimboli , 10 percent owner Andreessen Horowitz Lsv Fund Ii, L.p. , and 10 percent owner Ah Bio Fund Iii-b, L.p. .

EQRx Inc (EQRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EQRx Inc (EQRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EQRx Inc (EQRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EQRx Inc (EQRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

EQRx Inc Insider Transactions

No Available Data

What does Century Therapeutics Inc do?

Who are the key executives at Century Therapeutics Inc?

Eli Casdin is the director of Century Therapeutics Inc. Other key executives at Century Therapeutics Inc include VP of Finance and Operations Douglas Carr , Chief Operations Officer Adrienne Farid , and Chief Technology Officer Gregory Russotti .

Century Therapeutics Inc (IPSC) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Century Therapeutics Inc (IPSC). Other recent insider transactions involving Century Therapeutics Inc (IPSC) include a net sale of 27,386 shares made by Gregory Russotti , a net sale of 60,838 shares made by Adrienne Farid , and a net sale of 2,029 shares made by Douglas Carr .

In summary, during the past 3 months, insiders sold 1,316 shares of Century Therapeutics Inc (IPSC) in total and bought 0 shares, with a net sale of 1,316 shares. During the past 18 months, 90,253 shares of Century Therapeutics Inc (IPSC) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 85,253 shares.

Century Therapeutics Inc (IPSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Century Therapeutics Inc Insider Transactions

No Available Data

What does Tenaya Therapeutics Inc do?

Who are the key executives at Tenaya Therapeutics Inc?

Eli Casdin is the director of Tenaya Therapeutics Inc. Other key executives at Tenaya Therapeutics Inc include director & Chief Executive Officer Faraz Ali , Chief Medical Officer Whittemore Tingley , and Chief Scientific Officer Timothy Hoey .

Tenaya Therapeutics Inc (TNYA) Insider Trades Summary

Over the past 18 months, Eli Casdin made no insider transaction in Tenaya Therapeutics Inc (TNYA). Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net sale of 25,800 shares made by Timothy Hoey , a net sale of 21,669 shares made by Faraz Ali , and a net sale of 19,491 shares made by Whittemore Tingley .

In summary, during the past 3 months, insiders sold 2,258 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 0 shares, with a net sale of 2,258 shares. During the past 18 months, 81,234 shares of Tenaya Therapeutics Inc (TNYA) were sold and 4,444,444 shares were bought by its insiders, resulting in a net purchase of 4,363,210 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tenaya Therapeutics Inc Insider Transactions

No Available Data

Eli Casdin Mailing Address

Above is the net worth, insider trading, and ownership report for Eli Casdin. You might contact Eli Casdin via mailing address: 1350 Avenue Of The Americas, Suite 1140, New York Ny 10019.

Discussions on Eli Casdin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.